Marketing Research and Consulting for the Pharma and Biotech Industries
Press
Healogix featured in Medical Marketing & Media November issue
Healogix contributed to the feature cover story for the November issue of Medical Marketing & Media on sales forces. Healogix CEO Harris Kaplan noted that companies are increasingly challenged to provide materials that are useful to their sales force but ...
December 1st, 2009 Read MoreHarris Kaplan quoted in the November issue of Start-up
Harris Kaplan and Jun Huangpu led the Inflammatory/Autoimmune panel session at the Windhover Therapeutic Partnership Conference in Boston, selecting the top 10 “projects to watch” in the coming year in that therapeutic category. Kaplan told Windhover’s emerging medical ventures magazine ...
November 23rd, 2009 Read MoreHealogix Appoints Art McKee Managing Director Pharmaceutical Marketing Research Practice
18-Year Industry Veteran Brings Extensive Market Research and Client Management Expertise to Healogix Healogix, a leading full service research based consultancy for the pharmaceutical and biotechnology industries, today announced the appointment of Art Mckee as Managing Director, Pharmaceutical Market Research ...
October 22nd, 2009 Read MoreSee Our Recent Ad in In Vivo Magazine
Healogix offers services to help biotech companies achieve maximum valuation…Click here to see the advertisement. ...
September 24th, 2009 Read MoreHarris Kaplan to Present at Bio2Device Group Dec. 8, 2009
Topic: “Science + Commercialization = Valuation. Building a Commercial Story that Resonates with Prospective Partners.” Speaker: Harris Kaplan, President and Chief Executive Officer, Healogix Date and Time: Tuesday, Dec.. 8, 2009, 6:00 – 9:00 pm Location: Location: TIPS Group Law ...
September 15th, 2009 Read MoreHarris Kaplan Featured in BioWorld Today
Healogix CEO Harris Kaplan was featured in the August 14, 2009, issue of BioWorld Today. Kaplan discussed the growing interest in patient-reported outcome instruments, which are increasingly becoming a critical component of all phases of a drug’s life cycle. Yet while PROs are popping up in everything from oncology to gastrointestinal therapy, the subjective endpoint tools are still difficult to refine for reliability. To read the article please click here ...
August 20th, 2009 Read MoreHealogix plays a role in $350M Bayhill – Genentech deal
Paul Westberg, VP of Business Development for Bayhill Therapeutics, wrote “I am pleased to say that all of the hard work by everyone who has contributed to the program, including Healogix, has resulted in a premier partnership with Genentech / Roche. Thanks for all of your recent work on this project.” Click here to view an article “Bayhill Therapeutics Snags $350M Deal with Genentech” in BioWorld Today. ...
July 2nd, 2009 Read MoreHarris Kaplan to Speak at BioScience Forum June 17th
Harris Kaplan presents “Crossing the Biotech-Pharma Chasm”. Click here to download this presentation. (PDF Format) ...
June 25th, 2009 Read MoreHealogix CEO Harris Kaplan spoke at the MRA Conference
Healogix CEO Harris Kaplan spoke at the MRA Conference, presenting on “How Pharma Marketing Research Is Changing.” Click Here to download his presentation. (PDF Format) ...
June 5th, 2009 Read MoreHarris Kaplan Reflects on Future of Obesity Market in “The Pink Sheet”
Healogix CEO Harris Kaplan discusses the future of drug development for obesity in the June 1 issue of “The Pink Sheet.” If you would like to read the article please click on the link below. You will need to be a current subscriber of the “The Pink Sheet”. http://www.thepinksheet.com/fdcreports/story/viewStory.do?targetAN=00710220009 ...
June 2nd, 2009 Read MoreOffice: 215.863.8160 | Fax: 215.830.5051 | Email: info@healogix.com